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Abstract
Simulation studies are commonly used to evaluate the performance of newly developed meta-
analysis methods. For methodology that is developed for an aggregated data meta-analysis,
researchers often resort to simulation of the aggregated data directly, instead of simulating individual
participant data from which the aggregated data would be calculated in reality. Clearly, distributional
characteristics of the aggregated data statistics may be derived from distributional assumptions
of the underlying individual data, but they are often not made explicit in publications. This paper
provides the distribution of the aggregated data statistics that were derived from a heteroscedastic
mixed effects model for continuous individual data. As a result, we provide a procedure for
directly simulating the aggregated data statistics. We also compare our distributional findings with
other simulation approaches of aggregated data used in literature by describing their theoretical
differences and by conducting a simulation study for three meta-analysis methods: DerSimonian
and Laird’s pooled estimate and the Trim & Fill and PET-PEESEmethod for adjustment of publication
bias. We demonstrate that the choices of simulation model for aggregated data may have a relevant
impact on (the conclusions of) the performance of the meta-analysis method. We recommend the
use of multiple aggregated data simulation models for investigation of new methodology to determine
sensitivity or otherwise make the individual participant data model explicit that would lead to the
distributional choices of the aggregated data statistics used in the simulation.
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1 Introduction
An aggregated data meta-analysis would collect the information (Di, Si, dfi) for study i, with Di the
estimated study effect size of interest (e.g., mean difference, Cohen’s d, log odds ratio), Si the estimated
standard error of the study effect size, and dfi the corresponding degrees of freedom for the standard
error∗ 1. The aggregated data is typically constructed from individual data (although a researcher may not
have access to this individual data). The aggregated data is then used to determine a pooled estimate of
the main effect size and to calculate other aspects related to the quality of the meta-analysis (e.g., measure
of heterogeneity, publication bias, sensitivity analyses).
To investigate the performance of meta-analysis methods, researchers often resort to simulation of
the aggregated data (Di, Si, dfi) directly, making certain distributional assumptions
4–7. While these
distributional assumptions may be plausible, the choices are not properly supported or defended by
an underlying statistical model on the individual data that would generate the aggregated data. On the
other hand, when individual data is being simulated8–10 there is limited discussion on the distributional
characteristics of the aggregated data, making simulations on an individual level difficult to compare with
simulations conducted at the aggregated level.
This paper discusses a (fixed and random effects) heteroscedastic mixed effects model for a continuous
outcome at an individual level where two groups (e.g., treatments) are being compared. The model
assumes three forms of heterogeneity. The first form is a bivariate random effect on the two mean
outcomes across studies, indicating heterogeneity in outcome level between individuals across studies.
The second form is a fixed heteroscedastic residual error for the two groups within a study, implying that
inter-individual variability within studies can depend on other variables (like treatment). The third form
is a random heteroscedastic residual error across studies, which would represent that inter-individual
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∗Depending on the meta-analysis approaches or applications, the degrees of freedom dfi may or may not play a role in the analysis.
For instance, the degrees of freedom is used in an investigation of residual heteroscedasticity with Bartlett’s test when studies have
(approximately) the same study sizes 1,2, but in medical sciences it is frequently ignored 3 .
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variability can also change with studies due to the selection of more homogeneous or heterogeneous
participants. We believe that this model has not been discussed for meta-analysis purposes so far. Based
on this model we will discuss distributional properties of the aggregated data (Di, Si, dfi), which is useful
to be able to simulate study data at an aggregated level directly.
These distributional properties will be compared with similar distributional properties of certain
other aggregated data simulation models from literature to investigate the plausibility of these choices.
Secondly, we will conduct a simulation study to investigate the impact of different distributional choices
on some well-known meta-analysis approaches. We selected the very popular pooled estimation method
of DerSimonian and Laird for the random effects meta-analysis model11, the popular Trim & Fill
method12,13 for adjustments of publication bias in meta-analysis practice14–16, and the PET-PEESE
approach8,9 also for adjustment of publication bias. The PET-PEESE method has been popular in at
least the economics field10.
In section 2 we describe our statistical model for individual participant data in detail, determine
distributional properties of the aggregated statistics, and provide a simulation procedure to simulate
aggregated data according to this model. The third section discusses alternative aggregated data
simulation models from literature. This is just a selection of approaches we have encountered in literature
and does not necessarily represent a complete overview. We discuss the differences with our approach as
well. The fourth section presents shortly the meta-analysis methods of DerSimonian and Laird, the Trim
& Fill method, and the PET-PEESE method. Section 5 presents a simulation study where the aggregated
data simulation models are being compared. We also provide the simulation settings and a selection
model for publication bias used in literature as well. Then finally we provide a discussion of the results
in Section 6.
2 Heteroscedastic Mixed Effects Model
Let Yijk be a continuous outcome variable for individual k = 1, 2, ..., nij in treatment group j = 0, 1 for
study i = 1, 2, ...,m. Treatment j = 0 represents the control group and treatment j = 1 is the treatment
under investigation. Note that we use treatment here, but it could be in principle any binary variable that
splits the data in two groups (e.g., sex, symptom, disease). The statistical model is described as follows:
Yijk = µ+ βj + Uij + εijk (1)
with µ the mean response at the control group, β0 = 0 for identifiable purposes, β1 the mean treatment
effect and typically the (association) parameter of interest, Uij the (latent) study heterogeneity for
treatment group j, and εijk a potentially heteroscedastic residual. We will assume that the random
Prepared using sagej.cls
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elements are normally distributed, such that
εijk|Vi ∼ N (0, σ2j exp {Vi}),
(Ui0, Ui1, Vi)
T ∼ N (0,Σ), (2)
with Vi a (latent) random heteroscedastic study effect on the residuals in (1), with Σ given by
Σ =


τ20 ρ01τ0τ1 ρ02τ0τ2
ρ01τ0τ1 τ
2
1 ρ12τ1τ2
ρ02τ0τ2 ρ12τ1τ2 τ
2
2

 ,
and εijk and (Ui0, Ui1) being independent conditionally on Vi. It should be noted that our assumptions of
normality are not uncommon for the analysis of clinical trials and observational studies17,18. Furthermore,
heteroscedastic hierarchical models defined by (1) and (2) have been discussed in literature as well19,20,
but not in the context of meta-analysis.
Our model describes study heterogeneity (Uij) on the mean response, indicating that the outcome level
may vary with studies, but that this form of heterogeneity is not the same for both treatment groups. This
may not be unrealistic when the treatment group would fully cure a disease but the control group does
not, assuming that variability within a population is larger when it is composed of healthy and diseased
individuals. It is this form of heterogeneity that leads to the (well-known) random effects meta-analysis
model at the aggregated level (see Section 2.1). When the heterogeneity would be identical for both
treatment groups (ρ01 = 1 and τ1 = τ2), we may only observe heterogeneity at the individual level data
for each treatment group, but not necessarily at the aggregated study effect (again see Section 2.1).
Furthermore, we also assume that the residual variability, which represents inter-individual variability,
is treatment dependent (i.e., σ0 and σ1 may be different). This is not uncommon in several areas of
medicine (e.g., hypertension treatment) where treatment is not just affecting the level of the outcome in
a population, but also its variability. Our model also describes a residual heteroscedasticity that is study
dependent (Vi). This could be related to the selection of participants in a study, leading to a study with
either more homogeneous or less homogeneous participants. For instance, a clinical trial with mostly
men at a specific age group would show less inter-individual variability than a trial with both sexes and
a larger variety in age groups. Combining these different trials in a meta-analysis results in a random
residual heteroscedasticity. Here we assume that we do not have any complementary data to investigate
or eliminate such heteroscedasticity, implying the necessity of Vi in model (1).
Model (1) can be rewritten into Yijk = µ+ βj + Uij + τjZijk exp {0.5Vi}, with Zijk i.i.d. standard
normally distributed residuals (i.e., Zijk ∼ N (0, 1)), which are independent of the random effects Ui0,
Ui1, and Vi. This formulation demonstrates immediately that the selected model (1) with assumptions
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(2) has introduced a correlation between the residuals and the random location effects. In case we choose
ρ02 = ρ12 = 0, the error structure in (1) and the study treatment heterogeneity Uij will be independent.
It also shows that the marginal distribution of Yijk is not normal anymore, due to the product of a normal
and log normal random variable, unless τ2 = 0 of course.
Finally, the distribution of Ui0 − Ui1 and Vi is bivariate normally distributed with mean 0 and a
variance-covariancematrix given by
(
τ20 − 2ρ01τ0τ1 + τ21 τ2[ρ02τ0 − ρ12τ1]
τ2[ρ02τ0 − ρ12τ1] τ22
)
.
The difference Ui0 − Ui1 is important in Section 2.1 when we determine and discuss the study
effect size. The correlation coefficient ρ between Ui0 − Ui1 and Vi is thus equal to ρ = [ρ02τ0 −
ρ12τ1]/
√
τ20 − 2ρ01τ0τ1 + τ21 . We will demonstrate that the study effect size and its corresponding
standard error will always be dependent even when Ui0 − Ui1 and Vi are independent (i.e., ρ02τ0 =
ρ12τ1), unless τ2 = 0 of course.
2.1 Aggregated Effects Sizes and Standard Errors
A popular effect size used in meta-analysis calculated for each study is the (raw) mean difference between
the two treatment groups†, i.e.,
Di = Y¯i0 − Y¯i1, (3)
with Y¯ij =
∑nij
k=1 Yijk/nij the average response for study i at treatment j. Using model (1), we can
rewrite the effect size into
Di = β1 + Ui0 − Ui1 + exp {0.5Vi}
[
σ0Z¯i0 − σ1Z¯i1
]
, (4)
with Z¯ij =
∑nij
k=1 Zijk/nij the average standardized residuals for treatment j in study i. Note that (4) has
the same structure as the standard random effects model for aggregated data meta-analysis (model (11)
in Section 3). The difference Ui0 − Ui1 ∼ N(0, τ20 − 2ρ01τ0τ1 + τ21 ) represents the study heterogeneity
of effect sizes, but it disappears when ρ01 = 1 and τ0 = τ1.
The conditional distribution of the effect size Di, given the three random effects Ui0, Ui1, and Vi, is
given by a normal distribution with mean β1 + Ui0 − Ui1 and variance exp {Vi}
[
σ20/ni0 + σ
2
1/ni1
]
. A
†The raw mean difference is more common to use when all studies measure the outcome on the same scale (e.g., hypertension
treatment for blood pressure). In the educational or social sciences, it is common to have scales that may vary with study and it
would be more appropriate to divide the mean difference by a standard deviation to create a standardized measure of effect size in
the form of Cohen’s d 21 . We will assume a common scale.
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larger study will demonstrate a smaller residual variance, since the sample sizes ni0 and ni1, which will
then be smaller in other studies, will reduce the residual variance, but it could potentially be compensated
by a larger inter-individual variability (Vi > 0). However, we do not assume a direct relation between
a positive value for Vi and the sample size ni0 and ni1 (i.e., P (Vi > 0|ni0, ni1) = P (Vi > 0)). The
conditional distribution of Di given only Vi is also given by a normal distribution, but now with mean
and variance given by
E(Di|Vi) = β1 + τ−12 [ρ02τ0 − ρ12τ1]Vi,
VAR(Di|Vi) = (1− ρ202)τ20 + 2(ρ02ρ12 − ρ01)τ0τ1 + (1− ρ212)τ21
+exp {Vi}
[
σ20/ni0 + σ
2
1/ni1
]
.
(5)
Finally, the marginal distribution function for Di is less tractable when Vi is non-degenerative,
since the distribution of the product of a log normal and a normal distributed random variable (i.e.,
exp {0.5Vi}
[
σ0Z¯i0 − σ1Z¯i1
]
) is unknown whether they are dependently or independently distributed
(as we already mentioned for Yijk). However, we can determine the mean and variance of Di and they
are given by
E(Di) = β1,
VAR(Di) = τ
2
0 − 2ρ01τ0τ1 + τ21 + exp
{
τ22 /2
}
[σ20/ni0 + σ
2
1/ni1].
(6)
Note that correlation coefficient ρ = [ρ02τ0 − ρ12τ1]/
√
τ20 − 2ρ01τ0τ1 + τ21 does not play a role in
the variance of Di, due to the independence of Ui0 − Ui1 and σ0Z¯i0 − σ1Z¯i1. Thus the variance
is just the sum of the variance of the heterogeneity Ui0 − Ui1 and the variance of the residual
exp {0.5Vi}
[
σ0Z¯i0 − σ1Z¯i1
]
.
The estimated standard error Si for the effect size Di within one study (thus being unaware of any
possible random effect Ui0 − Ui1 across studies) can be estimated in different ways3. If we do not
want to make any assumptions on the equality of residual variances for the two treatment groups in
model (1), it is most reasonable to estimate the standard error Si by S
2
i = S
2
i0/ni0 + S
2
i1/ni1, with
S2ij =
∑nij
k=1(Yijk − Y¯ij)2/(nij − 1) the sample variance for treatment j in study i‡. Using model (1),
we can rewrite this sample variance S2ij into σ
2
j exp {Vi}χ2ij/(nij − 1), with χ2ij =
∑nij
k=1(Zijk − Z¯ij)2
‡Under assumption of homogeneous residual variances within studies (σ2
0
= σ2
1
), we may choose the pooled variance S2
i
=
[n−1
i0
+ n−1
i1
]
[
(ni0 − 1)S2i0 + (ni1 − 1)S
2
i1
]
/ [ni0 + ni1 − 2], instead of S2i = S
2
i0
/ni0 + S2i1/ni1. Derivations on this
pooled variance using our model (1) with assumptions (2) can be implemented in the same way as the derivations we will apply
to S2
i
= S2
i0
/ni0 + S2i1/ni1. These derivations are actually somewhat simpler than for our choice of S
2
i
= S2
i0
/ni0 + S2i1/ni1
and it leads to a central chi-square distribution with ni0 + ni1 − 2 degrees of freedom conditionally on Vi and when properly
scaled.
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a chi-square distributed random variable with nij − 1 degrees of freedom. Thus the variance S2i is now
distributed as
S2i = exp {Vi} [σ20χ2i0/(ni0(ni0 − 1)) + σ21χ2i1/(ni1(ni1 − 1))], (7)
with an expectation equal to E(S2i ) = exp
{
τ22 /2
}
[σ20/ni0 + σ
2
1/ni1] and a variance equal to
VAR(S2i ) = 2 exp
{
2τ22
} [
σ40/(n
2
i0(ni0 − 1)) + σ41/(n2i1(ni1 − 1))
]
+exp
{
τ22
} (
exp
{
τ22
}− 1) [σ20/ni0 + σ21/ni1]2 . (8)
The random variable σ20χ
2
i0/(ni0(ni0 − 1)) + σ21χ2i1/(ni1(ni1 − 1)) is approximately distributed as
[σ20/ni0 + σ
2
1/ni1]χ
2
dfi
/dfi, with χ
2
dfi
a chi-square distributed random variable with dfi degrees of
freedom. The number of degrees of freedom is given by22,23
dfi =
[
σ20χ
2
i0/(ni0(ni0 − 1)) + σ21χ2i1/(ni1(ni1 − 1))
]2
σ40χ
4
i0/ [n
2
i0(ni0 − 1)3] + σ41χ4i1/ [n2i1(ni1 − 1)3]
. (9)
This number of degrees of freedom is bounded from above by ni0 + ni1 − 2 and from below by
min {ni0 − 1, ni1 − 1} (Van den Heuvel, 2010). In case the sample sizes are equal (ni0 = ni1) and
the residual variances are equal (σ20 = σ
2
1), the random variable χ
2
dfi
becomes chi-square with dfi =
ni0 + ni1 − 2 degrees of freedom. The distribution of S2i in this general setting (7) using model (1) with
assumptions (2) is clearly intractable, but becomes approximately equal to a chi-square distribution when
Vi becomes degenerate in zero.
Note thatDi and S
2
i are independent conditionally on Vi, due to independence of the random variables
χ2i0, χ
2
i1, Z¯i1, Z¯i1, andUi0 − Ui1. Here we have used the assumption of normality to obtain independence
between the mean Z¯ij and variance S
2
ij (conditionally on Vi). Using this independence, (4), and (7),
the joint distribution of Di and S
2
i is now a mixture of the product of the two conditional distribution
functions for Di|Vi and S2i |Vi. This implies that Di and S2i are never independent, irrespective of the
value of ρ, unless Vi is degenerated. The covariance betweenDi and S
2
i is equal to
COV(Di, S
2
i ) = E
[
(Di − β1)S2i
]
,
= τ−12 [ρ02τ0 − ρ12τ1]E [Vi exp {Vi}] [σ20/ni0 + σ21/ni1],
= τ2[ρ02τ0 − ρ12τ1] exp
{
τ22 /2
}
[σ20/ni0 + σ
2
1/ni1],
(10)
and depends on the covariance of Ui0 − Ui1 and Vi (see Section 2). The covariance in (10) vanishes when
the heterogeneity and heteroscedasticity are unrelated. Using the variance of Di in (6) and the variance
of S2i in (8) the correlation betweenDi and S
2
i can be obtained as well.
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2.2 Procedure for Simulating Aggregated Data
One approach is to simulate individual data via model (1) for all m studies and then calculate all
the necessary aggregated data statistics Di, S
2
i , and dfi per study. This requires input values for the
sample sizes m, ni0, and ni1 and all parameters in model (1) and (2). Alternatively, we could simulate
the aggregated data statistics directly. Then we only need to set values for the following parameters:
sample sizes m, ni0, and ni1, treatment effect β1, variance component τ
2 = τ20 − 2ρ01τ0τ1 + τ21 for
a heterogeneous treatment effect, variance component τ22 for a random heteroscedasticity, correlation
coefficient ρ = τ−1[ρ02τ0 − ρ12τ1] between heterogeneity and heteroscedasticity, and residual variances
σ20 and σ
2
1 . Here we describe the aggregated approach.
Since studies often have different sample sizes we first need to choose a distribution for the sample
sizes ni0 and ni1. Although alternative approaches could be used, we first draw one sample size ni
for study i using a mixture of a Poisson-Gamma distribution (i.e., an overdispersed Poisson). We draw
a random variable γi from a gamma distribution Γ (a, b) with shape and scale parameters a and b,
respectively, (having mean a/b and variance a/b2) and then conditionally on this result we draw a
sample size ni from a Poisson distribution with mean parameter λi = λ0 exp {γi}. Then we split the
sample size ni into ni0 and ni1 using a Binomial distribution. We assumed that the distribution of
ni0|ni ∼ Bin(ni, p), with p a proportion which can take different values to create potential imbalances
in sample sizes for the two groups.
Since Di and S
2
i are independently distributed given Vi and χ
2
i0, χ
2
i1, and Vi are also mutually
independent, we could now independently draw χ2i0, χ
2
i1, and Vi for study i using the chi-square
distributions with ni0 − 1 and ni1 − 1 degrees of freedom and the normal distribution N (0, τ22 ),
respectively. Then S2i can be calculated directly using equation (7) and Di can be directly drawn from
a normal distribution using the mean and variance in (5). Note that the mean can be rewritten into
β1 + τ
−1
2 τρVi and the variance into τ
2(1− ρ2) + exp{Vi}σ2i , with σ2i = σ20/ni0 + σ21/ni1, using only
parameters at the aggregated level. The degrees of freedom can be calculated from (9) if this would be
needed.
It should be noted that we need two chi-square distributed random variables χ2i0 and χ
2
i1 to be able
to obtain the exact distribution of S2i given Vi and to calculate the degrees of freedom dfi properly.
Although we could argue that one chi-square distributed random variable χdfi would be appropriate
based on Satterthwaite approximation theory, it is not that easy to simulate since we need to know the
degrees of freedom dfi in (9). Indeed, this degrees of freedom is based on the data and we do not know
its distribution, making a simulation of one chi-square distributed random variable more complicated.
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3 Simulation of Aggregated Data in Literature
In this section we will provide an overview of a few simulation models that we have encountered in
literature to support investigations of the performance of meta-analysis approaches. We will show that
the distributional properties of the aggregated data Di, S
2
i , and dfi for a meta-analysis that we obtained
from our heterogeneous and heteroscedastic individual participants data model (1) deviates from what is
normally used in literature.
The simulation models used in literature all uses the well-known random effects model11,24 for the
study effect size Di at the aggregated level that is given by
Di = θ + Ui + εi, (11)
with θ the mean study effect of interest, Ui ∼ N (0, τ2) a random effect for study i to accommodate
study heterogeneity on the treatment effect (i.e., θ + Ui is the effect size for study i), εi ∼ N (0, σ2i )
the residual for study i, and Ui and εi independent. Clearly, model (11) is identical to our model (4),
with θ = β1, Ui = Ui0 − Ui1 and εi = exp {0.5Vi}
[
τ0Z¯i0 − τ1Z¯i1
]
, but the distributional assumptions
on normality and independence only agree with our setting when the random heteroscedasticity vanishes
(i.e., τ2 = 0). The variances τ
2 and σ2i in model (11) would become equal to τ
2 = τ20 − 2ρ01τ0τ1 + τ21
and σ2i = exp{τ22 /2}[σ20/ni0 + σ21/ni1], respectively, under our model (4).
Differences between the aggregated data simulation models in literature are typically determined by
the choice of distribution function for the standard deviation Si. The choice of distributions have been the
central chi-square for S2i in Sidik and Jonkman
25 and Brockwell and Gordon4, the non-central chi-square
for S2i in Ning et al.
7, and the gamma distribution for Si in Duval and Tweedie
13. Note that these choices
of distributions are different from our derived distribution of S2i in (7), unless we assume that there
is no residual heteroscedasticity at all (i.e., σ = σ0 = σ1 and τ2 = 0). Without heteroscedasticity, we
would also obtain a variance S2i that is related to a central chi-square distribution when we would change
our estimator S2i into S
2
i = S
2
p [n
−1
i0 + n
−1
i1 ], with S
2
p =
[
(ni0 − 1)S2i0 + (ni1 − 1)S2i1
]
/ [ni0 + ni1 − 2]
the pooled variance within study i. However, we would still include different sample sizes to obtain
differences in study size, which is often ignored when the aggregated data simulation studies are
conducted. Furthermore, we are unaware of distributional assumptions in model (1) that would lead
to a non-central or gamma distribution for S2i or Si, respectively.
There is an important other difference between our aggregated data simulation and the simulations
performed in literature. Our simulation would drawDi independently from S
2
i when conditioned on the
random heteroscedastic effect Vi. Thus dependency between Di and S
2
i is indirectly created through
the random variable Vi and with a covariance given in (10). In literature, the dependency between Di
and S2i is derived directly through S
2
i , since the residuals in (11) are typically being drawn from a
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normal distribution with mean zero and variance σ2i = S
2
i . Although Di and S
2
i are dependent in this
way, the covariance between Di and S
2
i is still equal to zero and therefore differs from our setting.
We would also obtain a covariance of zero when either Vi is degenerated (but then Di and S
2
i are
independent) or otherwise when Ui0 − Ui1 and Vi are independent. We believe that the assumption
VAR(εi|S2i ) = S2i in model (11) is highly unlikely in reality, as our IPD model shows, although we are
aware that both estimation approaches of DerSimonian and Laird11 and Hardy and Thompson24 assumed
that the standard error Si was the true standard deviation of the residual εi in model (11). However, this
does not imply that we should also simulate according to this assumption.
3.1 Central Chi-Square Distributed S2i
For the simulation of log odds ratios in a meta-analysis, Brockwell andGordon4 and Sidik and Jonkman25
simulated the log odds ratioDi according to model (11) with VAR(εi|S2i ) = S2i , S2i = 0.25χ2i , and χ2i a
chi-square distributed random variable with only one degrees of freedom (dfi = 1). They also restricted
the value of S2i to be within (0.009, 0.6) to conform with a typical distribution of the variances of log
odds-ratios in practice4,25. For mean differences we do not think that we should implement these variance
restrictions. In their comparisons of several meta-analysis methods of pooling log odd ratios they did not
make use of the dfi in any way. They selected a mean study effect of θ = 0.5 and evaluated eleven
different values for the heterogeneity τ2 in the range of 0 to 0.1.
3.2 Non-Central Chi-Square Distributed S2i
For an investigation of a publication bias method, Ning et al.,7 simulated the study effect size Di
according to model (11) with condition VAR(εi|S2i ) = S2i . The mean effect size was taken equal to
θ = 0.4 and the heterogeneity was selected equal to τ = 0.5 and τ = 1. To create the variance S2i , they
draw a normally distributed random variable Zi ∼ N(0.25, 0.5) and calculated the variance by S2i = Z2i .
The distribution of this variance is equal to a non-central chi-square distribution with non-centrality
parameter equal to 1/8 (= (0.25)2/0.5). They did not implement the degrees of freedom dfi.
3.3 Gamma Distributed Si
For an investigation of the Trim & Fill method for publication bias, Duval and Tweedie12,13 simulated the
study effect size Di according to model (11) with restriction VAR(εi|S2i ) = S2i . They assumed that both
the mean study effect θ and heterogeneity τ2 were equal to zero. The standard error Si was drawn from
a Gamma distribution with parameters 3 and 1/9 (i.e., Si ∼ Γ(3, 1/9)). Their argument for this choice is
that it provides a more typical funnel plot than a uniform distribution for Si, which was applied by Light
and Pillemer26. They did not specify which parametrization of the gamma distribution they selected, but
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we guess that the mean of Si would be equal to 1/3 (= 3× 1/9) and with a variance equal to 1/27
(= 3× (1/9)2), considering the values for precision S−1i they used in their funnel plots.
4 Meta-Analysis Methods
In this section we briefly describe the three meta-analysis approaches that we will study in our simulation:
the DerSimonian and Laird pooled analysis approach and two publication bias adjustment methods: Trim
& Fill and PET-PEESE.
4.1 DerSimonian and Laird Method
DerSimonian and Laird11 assumed that the study effect size Di follows model (11) in combination with
the normality assumptions on the random effects and with a known variance σ2i equal to the observed
S2i . The pooled estimate for θ is given by the weighted average θˆDSL =
∑m
i=1 wiDi/
∑m
i=1 wi, with
weight wi equal to wi = [τˆ
2 + S2i ]
−1 and τˆ2 and estimator of the variance component for the study
effect heterogeneity. They proposed the estimator given by
τˆ2DSL = max
{
0,
Q− (m− 1)∑m
i=1 S
−2
i −
∑m
i=1 S
−4
i /
∑m
i=1 S
−2
i
}
,
with Cochran’s Q-statistic given by Q =
∑m
i=1[S
−2
i (Di − D¯)2] and with D¯ the weighted average
given by D¯ =
∑m
i=1[S
−2
i Di]/
∑m
i=1 S
−2
i . The accompanied standard error S of the pooled estimate
θˆDSL is given by S
2 = 1/
∑m
i=1 wi. DerSimonian and Laird
11 are not very clear on how to calculate
confidence intervals, but based on the work of Cochran1, we assume that the degrees of freedom of S is
equal tom− 1 and use
θˆDSL ± t−1α/2,m−1S
for the (1− α)100% confidence interval, with t−1q,d the (1 − q) upper quantile of the t-distribution with d
degrees of freedom. To obtain DerSimonian and Laird’s pooled estimates θˆDSL with its 95% confidence
limits we applied the R package “meta”27.
4.2 Trim & Fill Method
The Trim & fill method has been described in detail in Duval and Tweedie12,13. In short, studies are
first ranked based on their distance from the pooled treatment effect estimated by the random effects
model (11), i.e., ranking distances |Di − θˆ|. Next, the number of unobserved studies is estimated using
for instance estimator L0 = [4Tm −m(m+ 1)]/[2m− 1], where Tm is the Wilcoxon rank sum test
statistic estimated from the ranks of studies with Di > θˆ (here we assume that θˆ is positive and it is
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more likely that studies with effect sizes below θˆ are potentially missing). We then trim off the L0 most
extreme studies (i.e., studies with positive effect sizes furthest away from zero) and re-estimate the pooled
treatment effect θˆ without these studies. Then all studies are ranked again, based on their distance to the
new pooled estimate, and L0 is recomputed. This procedure is repeated until it stabilizes (L0 does not
change anymore) and we obtain a final estimate θˆ and a final estimate L0 of the number of studies
missing. Then we impute L0 studies by mirroring the L0 studies with the highest effect sizes around the
final estimate θˆ and provide it with the standard error Si from the mirrored study. After imputation, a final
pooled estimate with standard error is provided using the random effects model on all m+ L0 studies.
We used the function “trimfill” in the R package “metafor”, with the average treatment effect estimated
using the random effects model28.
4.3 PET-PEESE Method
The PET-PEESE method is based on the understanding of the bias function in case publication bias is
present. Under certain conditions, this bias function can be determined explicitly9, but it is a complicated
function of the true effect size and approximations are needed. One approximation is based on Egger
test29, which investigates the linear relation between the t-value Ti = Di/Si and the precision S
−1
i , i.e.,
Ti = α0 + α1S
−1
i + ei, (12)
with α0 and α1 the intercept and slope parameter, respectively, and with residual ei ∼ N
(
0, ν2
)
. An
intercept deviating from zero (α0 6= 0) would indicate publication bias, while the slope in (12) represents
the effect size (i.e., α1 = θ). However, Stanley and Doucouliagos
9 demonstrated that the OLS estimator
αˆ1 from (12) would be a biased estimator when it deviates from zero. Thus when null hypothesis
H0 : α1 = 0 is rejected, they proposed to use the weighted linear regression between study effect Di
and variance S2i , i.e.,
Di = γ0 + γ1S
2
i + ei, (13)
with weights S−2i and report the estimate γˆ0 as the overall treatment effect θ. This part is called the
Precision Effect Estimate with SE (PEESE). In case null hypothesis H0 : α1 = 0 is not rejected, the
reported estimate is αˆ1, which is referred to as the Precision Effect Test (PET). Note that model (13)
was suggested earlier by Moreno et al.30 We used Procedure GLM in SAS to carry out the PET-PEESE
method.
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5 Simulation Study
We will first discuss the simulation settings for our own aggregated data meta-analysis. Then from these
settings we will determine appropriate settings for the simulation models from literature to make the
comparison of these simulations with our simulations as fair as possible. Then after defining the settings,
we will discuss the publication bias approach and its settings that were used in the simulation study for
the publication bias methods. Then finally we report the results of the simulations.
5.1 Simulation Settings
We selected two levels for the number of studies in the simulated meta-analysis (m ∈ {10, 50}), but we
chose to fix the parameters for simulating the sample sizes within studies (λ = 100, a = b = 1, p = 0.5).
This results in an expected number of sample sizes within each study that is equal to ni0 = ni1 = 50,
but they could vary strongly from study to study due to the overdispersed Poisson distribution and vary
within study due to a binomial division of the total sample size ni0 + ni1. We considered no treatment
effect and two positive levels of treatment effect (β1 ∈ {0, 2, 5})§. The residual variances for the two
treatment groups were kept fixed at the levels σ20 = 100 and σ
2
1 = 64, respectively. For the variance
of treatment heterogeneity we selected three levels τ2 ∈ {0, 2, 5}, with τ2 = τ20 − ρ01τ0τ1 + τ21 . The
variance for the random heteroscedasticity was selected at two levels, τ22 ∈ {0, log(2)}, to simulate
effect sizes with and without a random heteroscedasticity. Finally, we selected three levels for the
correlation coefficient between the heteroscedasticity and heterogeneity ρ ∈ {−0.7, 0, 0.7}, with ρ =
[ρ02τ0 − ρ12τ1]/
√
τ20 − 2ρ01τ0τ1 + τ21 . Clearly, when τ22 = 0, the correlation coefficient ρ would not
play any role in the simulation. Thus we will study 66 = 18 + 48 different simulation settings. Each
setting will simulate 1000 meta-analysis studies.
Relating our simulation settings to the parameters of model (11), we obviously obtain that θ ∈ {0, 2, 5}
and τ2 ∈ {0, 2, 5}, since they are direct translations of β1 and τ2 given above. Thus we could draw a
normally distributed random variable Ui having a mean equal to θ and a variance equal to τ
2 for all the
simulation models from literature. Without random heteroscedasticity (τ22 = 0), the residual variance
in (11) would become equal to σ2i = σ
2
0/ni0 + σ
2
1/ni1. Using the settings σ
2
0 = 100, σ
2
1 = 64, and
ni0 = ni1 ≈ 50, the variance σ2i would become on average equal to approximately 3.28, but it will
vary across studies due to randomness in ni0 and ni1. Thus when instead we will draw σ
2
i directly
from the central chi-square, the non-central chi-square, or the gamma distribution, we need to choose
the distributional parameters such that the expected value is close to 3.28. For the central chi-square
§Note that we could exclude values for µ in model (1), since this parameter cancels out at an aggregated level when mean differences
are calculated.
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distribution we use σ2i = 3.28χ
2
1, having a mean of 3.28 and a standard deviation of 3.28
√
2. For the non-
central chi-square distribution we use σ2i = 3(0.3 + Zi)
2, with Zi ∼ N(0, 1). The expected value is then
equal to 3(1 + 0.09) = 3.27 and the standard deviation is 3
√
2(1 + 0.18). For the gamma distribution
we choose the parameter settings Γ(9, 5) for standard error Si, leading to a mean of 9/5 ≈
√
3.28 and a
standard deviation of 3/5.
In case of random heteroscedasticity (τ22 = log(2) > 0), the residual variance in (5) for the simulation
models from literature would just increase on average with a factor
√
2 = exp{0.5 log(2)} compared to
the non-random heteroscedasticity setting (τ22 = 0). These simulation models do not alter the relation
between Di and Si when a random heteroscedasticity is introduced. Thus for a setting with random
heteroscedasticity, we should just multiply the random variables from the setting without random
heteroscedasticity with the factor
√
2when we use the simulation models with the chi-square distributions
and
4
√
2when we use simulation model with the gamma distribution. Thus correlation coefficient ρ, which
affects the correlation between Di and Si in our simulation model, does not affect any of the simulation
models from literature.
5.2 Publication Bias
The performance of the Trim & Fill and PET-PEESE method in literature was investigated with the
same data-driven publication bias selection approach. All studies with a significant effect size are never
being excluded from the meta-analysis. For the remaining (non-significant) studies, a standard uniform
distributed random variable is generated U(0, 1) for each study and the study is included in the meta-
analysis when the value of the uniform distributed random variable is less than pipub.
The level of significance and the parameter pipub are chosen such that the desired publication rate over
all studies is approximately 70%. A study is considered significant when the standardized effect size
Di/Si satisfies Di/Si > zα, with zq the upper q
th quantile of the standard normal distribution function.
We used this z-test because the aggregated data simulation models from literature did not implement
degrees of freedom dfi, ruling out the use of a t-test. In this way a comparison of all aggregated data
simulation models would be fair. For θ = 0 and θ = 2 we used as significance level of α = 0.05, but
for θ = 5 we used the smaller significance levels of α = 0.0013 (three sigma), since some settings had
more than 70% significant studies. Thus publication bias depends on the relative performance of other
studies. We then pragmatically tuned the parameter pipub for the different settings to obtain the target of
70%. Note that pipub would also be different for the different simulation models, due to the differences in
generating the variance S2i .
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5.3 Simulation Results DerSimonian and Laird
The results of the four aggregated data simulation models for m = 10 are provided in Table 1. Here we
did not include publication bias, since it is well-known that DerSimonian and Laird’s estimate would be
biased9,13. The correlation coefficient ρ for the random heteroscedastic model was set to ρ = 0 when we
studied heteroscedasticity.
Table 1. Comparison of aggregated data simulation models on bias (×10−3) and coverage probability (in %)
for the DerSimonian and Laird random effects estimator (m = 10; θ = 2; ρ = 0).
τ2
2
τ2
Central Non-central Gamma Mixture
Bias 95%CI Bias 95%CI Bias 95%CI Bias 95%CI
0
0 +8.5 0.941 +11.1 0.946 +26.3 0.946 +4.5 0.946
2 −7.0 0.896 +22.8 0.907 +12.7 0.924 +6.4 0.947
5 −14.9 0.929 +15.2 0.931 +9.2 0.940 +8.7 0.951
log(2)
0 +10.2 0.941 +13.3 0.946 +28.7 0.946 −6.1 0.944
2 −6.2 0.891 +28.7 0.899 +14.6 0.922 −7.9 0.946
5 −15.1 0.919 +22.2 0.924 +10.6 0.937 −11.1 0.950
All simulation models show hardly any bias, but there is a small difference in the coverage probability
for the 95% confidence intervals of the pooled effect size. The simulation model with the mixture
of chi-square distributed variances shows a nominal coverage probability, while the other simulation
models underestimate the coverage probability when there is heterogeneity. In case the number of studies
increases, the difference gets smaller, but remains present (data not shown). The heteroscedasticity
(ρ = 0), which just increases the residual variances for the simulation models (since there is no linear
correlation betweenDi and S
2
i ), does not seem to affect any of the results a lot.
5.4 Simulation Results on Trim & Fill
For the evaluation of the Trim & Fill method, we implemented the publication bias mechanism. For all
aggregated data simulation models, the average number of studies that were included was around 70%
(and it ranged from 67% to 73%). Table 2 shows the results on estimation bias and coverage probability
for the treatment effect of the Trim & Fill approach under homoscedasticity (τ22 = 0) form = 50 studies.
Results form = 10 are slightly worse (data not shown).
The simulation models show some different results with respect to bias and coverage probability.
The simulation models with the central and non-central distribution do not show any real bias when
heterogeneity is absent, while the simulation model with the mixture of chi-square distributions
shows a small positive bias at treatment effects θ = 2 and θ = 5 (Trim & Fill does not correct
enough). The coverage probability of the central and non-central chi-square are conservative, but they
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Table 2. Comparison of aggregated data simulation models on bias (×10−3) and coverage probability (in %)
for the Trim & Fill estimator (m = 50; τ 22 = 0).
θ τ2
Central Non-Central Gamma Mixture
Bias 95%CI Bias 95%CI Bias 95%CI Bias 95%CI
0
0 +6.9 0.976 +8.9 0.969 +28.7 0.902 +89.4 0.802
2 +232.8 0.748 +178.9 0.776 +130.1 0.833 +173.8 0.817
5 +398.1 0.703 +314.9 0.735 +258.7 0.803 +288.5 0.839
2
0 +1.0 0.991 +11.2 0.977 +192.8 0.875 +261.1 0.790
2 +261.2 0.734 +248.8 0.764 +308.3 0.781 +355.3 0.785
5 +495.3 0.645 +473.1 0.640 +434.5 0.752 +484.5 0.782
5
0 +0.8 0.988 +1.2 0.977 +114.3 0.908 +391.9 0.719
2 −3.1 0.797 −20.3 0.815 +272.2 0.776 +509.9 0.689
5 +221.8 0.767 +198.1 0.777 +524.4 0.693 +675.8 0.658
are underestimated with the gamma and the mixture of chi-square distributions. In the presence of
heterogeneity, all simulation models show real biases that increases with the size of heterogeneity. For
the central and non-central chi-square distribution, the absolute bias is highest for treatment effect θ = 2,
but for the mixture of chi-square distributions the bias is highest at treatment effect θ = 5. For the gamma
distribution, the absolute bias is higher at θ = 2 than at θ = 5 when heterogeneity is limited, but smaller
when heterogeneity is at the level of τ2 = 5. The mixture of chi-square distributions generally provides
the highest bias with respect to the other simulation models.
Random heteroscedasticity with ρ = 0 does not alter the results observed in Table 2, since it merely
increases the residual variance for the simulation models. However, when we select ρ = −0.7 or
ρ = 0.7, the correlation between heterogeneity and heteroscedasticity seems to change the results for our
aggregated data simulation model (see Table 3). A negative correlation increases the bias and lowers the
coverage, while a positive correlation eliminates the bias or changes it to a negative bias, but always with
highly liberal coverage probabilities. A negative correlation ρ = −0.7 introduces a negative correlation
between Di and Si and diminishes the positive correlation between Di and Si that was induced by
the publication bias mechanism, masking an asymmetry in the funnel plot that was introduced by the
publication bias. A positive correlation ρ = 0.7 enhances the publication bias, making the Trim & Fill
approach correct stronger. For θ = 0 the positive bias in Table 2 under homoscedasticity (or under
ρ = 0) is turned into a negative bias, while the observed positive bias for θ ∈ {2, 5} in Table 2 is almost
eliminated (Table 3).
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Table 3. Bias (×10−3) and coverage probability (in %) for the Trim & Fill estimator under heteroscedasticity
(m = 50).
θ τ2
ρ = −0.7 ρ = 0 ρ = 0.7
Bias 95%CI Bias 95%CI Bias 95%CI
0
2 +609.7 0.690 +172.4 0.815 -319.3 0.747
5 +796.6 0.709 +285.9 0.825 -344.9 0.779
2
2 +755.0 0.575 +334.4 0.787 -121.3 0.858
5 +942.0 0.600 +457.9 0.779 -123.7 0.873
5
2 +873.9 0.463 +437.7 0.701 +5.7 0.873
5 +1126.6 0.480 +587.1 0.676 +18.3 0.869
5.5 Simulation Results on PET-PEESE
For the evaluation of the PET-PEESE estimator, we also implemented the publication bias mechanism.
Since we used the same data as for the Trim & Fill approach, the average number of studies that were
included was around 70% (and it ranged from 67% to 73%). Table 4 shows the results on estimation bias
and coverage probability for the treatment effect of the PET-PEESE under homoscedasticity (τ22 = 0)
for m = 50 studies. Results for m = 10 are less severe for the simulation models with the central and
non-central chi-square distribution when the treatment effect is restricted (θ ∈ {0, 2}), but in all other
cases the results are more extreme form = 10 than form = 50.
Table 4. Comparison of aggregated data simulation models on bias (×10−3) and coverage probability (in %)
for the PET-PEESE estimator (m = 50; τ 22 = 0).
θ τ2
Central Non-Central Gamma Mixture
Bias 95%CI Bias 95%CI Bias 95%CI Bias 95%CI
0
0 +1.2 0.981 +1.9 0.971 −20.9 0.972 +106.3 0.957
2 +212.3 0.268 +241.2 0.267 +78.7 0.910 +192.2 0.956
5 +352.6 0.257 +400.4 0.259 +208.6 0.883 +337.5 0.956
2
0 +2.2 0.977 +2.5 0.954 +14.0 0.937 +129.4 0.949
2 +130.7 0.263 +157.6 0.264 +39.5 0.861 +199.6 0.945
5 +382.1 0.246 +423.4 0.235 +127.2 0.811 +273.8 0.945
5
0 −5.0 0.962 −5.4 0.943 −41.5 0.946 −281.5 0.947
2 −25.4 0.268 +16.1 0.281 +62.1 0.877 −228.2 0.955
5 +37.0 0.271 +114.1 0.271 +177.8 0.824 −113.2 0.950
For the PET-PEESEwe see biases for the simulationmodels with the central and non-central chi-square
distributions similar to their biases of the Trim & Fill approach, but the coverage probabilities are much
smaller when heterogeneity is present. The central and non-central chi-square simulation models simulate
studies with very small standard errors (i.e., mimicking extremely large studies in a meta-analysis). These
extreme studies, in combination with an independent heterogeneous study effect, have a strong influence
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on the estimation of the effect size and its standard error in a single meta-analysis. Since the heterogeneity
is independent of the standard error, the bias is less affected when averaged out over many meta-analyses,
but the confidence interval of the pooled study effect size from a single meta-analysis will not capture
the true parameter. The PET-PEESE does not incorporate the heterogeneity in the weights and therefore
underestimate the standard error, but the Trim & Fill does account somewhat for the heterogeneity.
The simulation model with the gamma distribution and the mixture of chi-square distributions seem to
show less bias with the PET-PEESE than with the Trim & Fill. The bias with PET-PEESE is limited and
acceptable for the simulation model with the gamma distribution, although the coverage probability is
liberal when heterogeneity is present. The coverage probability for the simulation model with a mixture
of chi-square distributions are very close to nominal, even though a small bias is frequently present. The
change from a positive bias for treatment effects θ ∈ {0, 2} to a negative bias when θ = 5, is difficult to
explain, but could be related to the high number of significant effect sizes. For θ = 5, Egger’s part hardly
plays a role in estimation of the pooled treatment effect, which is not the case for smaller treatment
effects. Also the other simulation models show a decline in the bias when the treatment θ changes from
{0, 2} to 5, suggesting it is related to the PET-PEESE approach.
Table 5. Bias (×10−3) and coverage probability (in %) for the PET-PEESE estimator under heteroscedasticity
(m = 50).
θ τ2
ρ = −0.7 ρ = 0 ρ = 0.7
Bias 95%CI Bias 95%CI Bias 95%CI
0
2 +2560.5 0.766 +238.3 0.955 −2112.5 0.785
5 +3909.2 0.664 +337.5 0.956 −3057.6 0.642
2
2 +2140.9 0.669 +153.9 0.937 −2487.0 0.780
5 +3292.8 0.562 +273.8 0.945 −3674.5 0.634
5
2 +1680.8 0.690 −118.8 0.938 −2530.4 0.762
5 +2729.8 0.581 −113.2 0.950 −3905.5 0.641
Similar to the Trim & Fill method, a random heteroscedasticity with ρ = 0 does not alter the results
observed in Table 4 a lot, since it does not change the correlation between Di and S
2
i compared to the
setting with homoscedasticity. However, when ρ = −0.7 or ρ = 0.7, we see a similar pattern as for the
Trim & Fill approach, but now the heteroscedasticity has a stronger effect (see Table 5). A negative
correlation ρ = −0.7 reduces the positive correlation between Di and Si induced by the publication
bias mechanism, failing the PET-PEESE to correct for publication bias. A positive correlation ρ = 0.7
enhances the publication bias and making the PET-PEESE over correct.
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6 Summary and Discussion
We discussed four simulation models for generating aggregated data in a meta-analysis study. All four
models use the well-known random effects model11 to generate study effect sizes, but each model used
their own distribution function for generating the standard error of the study effect size (a central chi-
square, a non-central chi-square, a gamma, and a mixture of chi-square distributions). We showed that the
mixture of chi-square distributions would follow naturally from a mixed model for individual participant
data (IPD), but the other three distributions could not be formulated directly from such an IPDmodel. The
simulation models with a central chi-square, non-central chi-square, and gamma distribution indirectly
created a dependency between the study effect size and its standard error, but without introducing a linear
dependency. For the mixture of chi-square distributions, a dependency between the study effect size and
its standard error was created through a random heteroscedasticity, in line with research on hierarchical
heteroscedastic multi-level models, which gave a zero correlation only when the heteroscedasticity is
unrelated to the study heterogeneity. The simulation models with a central and non-central chi-square
distribution, simulated studies with very small and relatively large standard errors, mimicking meta-
analyses with a large variety of study sizes, while the gamma distribution and the mixture of chi-square
distributions typically showed standard errors that belong to a smaller variety in study sizes.
Our simulation study showed that the choice of simulation model affects the conclusion of the applied
meta-analysis method. The well-known liberal coverage probabilities of the DerSimonian and Laird
method of pooled effect size4,24,31 was observed with the simulation models using the central and non-
central chi-square distribution, and to a lesser extent with the gamma distribution, but surprisingly not
with the mixture of chi-square distributions. The simulation model using this mixture of chi-square
distributions gave perfect nominal coverage probabilities.
All simulation models showed some biases for the PET-PEESE approachwhen heterogeneity is present
and the treatment effects are moderate to none. This influence of heterogeneity on the performance of
PET-PEESE is in line with literature9,10. However, they applied a different simulation model, where
the regression equations (12) and (13) are directly simulated using uniform and normal distributions.
Their biases are therefore somewhat different from ours, but this strengthen our point that performances
of meta-analysis methods are sensitive to simulation models. Indeed, in our own simulation study for
the PET-PEESE we demonstrated that the simulation model with the gamma distribution showed the
smallest bias and provided acceptable biases across all settings. Contrary, the simulation model with
the mixture of chi-square distributions gave biases of the pooled effect size even when heterogeneity
was not present, which was not seen with the other three simulation models. Finally, PET-PEESE was
sensitive to standard errors that belong to a larger variety of study sizes, since it gave very small coverage
probabilities for the pooled effect size when the central and non-central chi-square distributions were
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used with study heterogeneity. The simulated meta-analyses typically contained extremely small standard
errors that caused an underestimation of the variance of the pooled effect size. To our knowledge, this
sensitivity to study sizes has not been presented in literature before.
For the Trim & Fill approach, the simulation model with the gamma distribution showed larger biases
in the pooled treatment effect than for the PET-PEESE approach. This is in line with findings that PET-
PEESE seems to outperform the Trim & Fill approach9. However, the simulation models with the central
and non-central chi-square distributions did not show any large discrepancies between Trim & Fill and
PET-PEESE, arguing that Trim & Fill may not necessarily be worse than PET-PEESE. On the other hand,
the simulation models with the mixture of chi-square distributions showed substantial positive biases with
the Trim& Fill approach andmoderate negative biases with the PET-PEESE approachwhen the treatment
effect is strong, an observation not mentioned earlier. Interestingly though, this simulation model with
a mixture of chi-square distributions always showed coverage probabilities very close to nominal for all
settings for both the Trim & Fill and the PET-PEESE approach, despite the observed biases, contrary to
the other simulation models which showed (very) liberal coverage probabilities when heterogeneity is
present. Indirectly, the variability in coverage probabilities also showed that the simulation model affects
the mean squared error, since the coverage probability for the PET-PEESE is much smaller than for the
Trim & Fill approach when the simulation models with central and non-central chi-square distributions
are used with heterogeneous effect sizes. Thus mean squared errors are not just affected by publication
bias methods9, but also by the choice of simulation model.
When we introduce random heteroscedasticity, an element not studied in literature before, the Trim &
Fill and PET-PEESE approachmay fail completely in their estimation of the pooled treatment effect. This
effect could only be observed with our simulation model, since the simulation models with the central
chi-square, non-central chi-square, and the gamma distribution do not have a mechanism to change the
joint distribution of the study effect and its standard error. The failure of the publication bias method is
not unexpected, since the linear correlation between the study effect and its standard error is influenced by
the heteroscedasticity, which is unrelated to publication biases, and confuses the methods for publication
bias.
Our results demonstrated that the choice of simulation model for aggregated data meta-analyses can
have an influence on the conclusion of how well a particular meta-analysis approach performs. Most
publications in literature do not give any or strong arguments for their choice of simulation models and
could therefore implicitly bias their results or conclusions. We recommend the use of multiple simulation
models when meta-analysis approaches are being studied to provide a more fair view of the performance
of the meta-analysis approach. Otherwise we recommend that researchers provide a strong argument for
their choice of simulation model for the aggregated data and show that it would make sense in reality,
since not all simulation models we studied had a clear interpretation to statistical models at IPD.
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